DAS DEUTSCH-LUXEMBURGISCHE ABWASSERKLAERWERK ECHTERNACH-WEILERBACH AN DER SAUER. = LA STATION D'EPURATION GERMANO-LUXEMBOURGEOISE D'ECHTERNACH-WEILERBACH SUR LE SAUERMEURER R.1978; WASS. U. BODEN; DTSCH.; DA. 1978; VOL. 30; NO 5; PP. 111-115Article

Aspekte der Landespflege und der Gewässergüte beim Saarausbau in Rheinland-Pfalz - eine Zwischenbilanz = Aspects de la préservation du territoire et de la qualité des eaux dans l'aménagement de la Sarre en Rhénanie-Palatinat: un bilan intermédiaire = Aspects of environment control and water quality during the development of the Saar in Rhineland-Palatinate - an interim reportMEURER, R.Wasser und Boden. 1985, Vol 37, Num 12, pp 607-611, issn 0043-0951Article

Lack of effect of pertussis toxin on TNF-α-induced formation of reactive oxygen intermediates by human neutrophilsMEURER, R; MACINTYRE, D. E.Biochemical and biophysical research communications (Print). 1989, Vol 159, Num 2, pp 763-769, issn 0006-291XArticle

Effects of cyclooxygenase and lipoxygenase inhibitors on inflammation associated with oxazolone-induced delayed hypersensitivityMEURER, R; OPAS, E. E; HUMES, J. L et al.Biochemical pharmacology. 1988, Vol 37, Num 18, pp 3511-3514, issn 0006-2952, 4 p.Conference Paper

Trypanosoma cruzi: efficacy of the 2-substituted, 5-nitroimidazoles, MK-436 and L634,549, in tissue culture and miceMURRAY, P. K; HABBERSETT, M. C; MEURER, R. D et al.The American journal of tropical medicine and hygiene. 1983, Vol 32, Num 6, pp 1242-1250, issn 0002-9637Article

The role of CD18 in IL-8 induced dermal and synovial inflammationFORREST, M. J; EIERMANN, G. J; MEURER, R et al.British journal of pharmacology. 1992, Vol 106, Num 2, pp 287-294, issn 0007-1188Article

Can MDM2 and CDK4 make the diagnosis of well differentiated/dedifferentiated liposarcoma? An immunohistochemical study on 129 soft tissue tumoursALEIXO, P. B; HARTMANN, A. A; MENEZES, I. C et al.Journal of clinical pathology. 2009, Vol 62, Num 12, pp 1127-1135, issn 0021-9746, 9 p.Article

Characterization and species distribution of high affinity GTP-coupled receptors for human rantes and monocyte chemoattractant protein 1VAN RIPER, G; SICILIANO, S; FISCHER, P. A et al.The Journal of experimental medicine. 1993, Vol 177, Num 3, pp 851-856, issn 0022-1007Article

Pharmacology fo the dual inhibitor of cyclooxygenase and 5-lipoxygenase 3-hydroxy-5-trifluoromethyl-N-(2-(2-thienyl)-2-phenyl-ethenyl)benzo(b)thiophene-2-carboxamideBAILEY, P. J; DALLOB, A. L; ROSA, R et al.Arzneimittel-Forschung. 1988, Vol 38, Num 3, pp 372-378, issn 0004-4172Article

Biochemical and biological activities of 2,3-dihydro-6-[3-(2-hydroxymethyl)phenyl-2-propenyl]-5-benzofuranol (L-651,896), a novel topical anti-inflammatory agentBONNEY, R. J; DAVIES, P; ZAMBIAS, R et al.Biochemical pharmacology. 1987, Vol 36, Num 22, pp 3885-3891, issn 0006-2952Article

5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitorsEVANS, J. F; LEVEILLE, C; LUELL, S et al.Molecular pharmacology. 1991, Vol 40, Num 1, pp 22-27, issn 0026-895XArticle

L-656,224 (7-chloro-2-[(4-methoxyphenyl)methyl]-3-methyl-5-propyl-4-benzofuranol): a novel, selective, orally active 5-lipoxygenase inhibitorBELANGER, P; MAYCOCK, A; LETTS, L. G et al.Canadian journal of physiology and pharmacology. 1987, Vol 65, Num 12, pp 2441-2448, issn 0008-4212Article

Synthesis and structure-activity relationships of a novel class of 5-lipoxygenase inhibitors. 2-(phenylmethyl)-4-hydroxy-3,5-dialkylbenzofurans: the development of L-656,224LAU, C. K; BELANGER, P. C; FORD-HUTCHINSON, A. W et al.Journal of medicinal chemistry (Print). 1989, Vol 32, Num 6, pp 1190-1197, issn 0022-2623, 8 p.Article

Substituted 2-aminopyridines as inhibitors of nitric oxide synthasesHAGMANN, W. K; CALDWELL, C. G; CHABIN, R. M et al.Bioorganic & medicinal chemistry letters (Print). 2000, Vol 10, Num 17, pp 1975-1978, issn 0960-894XArticle

Optimal humanization of 1B4, an anti-CD18 murine monoclonal antibody, is achieved by correct choice of human V-region framework sequencesSINGER, I. I; KAWKA, D. W; FORREST, M. J et al.The Journal of immunology (1950). 1993, Vol 150, Num 7, pp 2844-2857, issn 0022-1767Article

Development, synthesis, and biological evaluation of (-)-trans-(2S,5S)-2-[3-(2-oxopropyl)sulfonyl]-4-n-propoxy-5-(3-hydroxypropoxy)-phenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran, a potent orally active platelet-activating factor (PAF) antagonist and its water-soluble prodrug phosphate esterGIROTRA, N. N; BIFTU, T; DAVIES, P et al.Journal of medicinal chemistry (Print). 1992, Vol 35, Num 19, pp 3474-3482, issn 0022-2623Article